Detection of CFTR mutations using ARMS and low-density microarrays

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Amplification Refractory Mutation System (ARMS) is a standard method for identifying specific genomic mutations.
• Current ARMS assays are low-throughput and require gel electrophoresis for mutation identification.
• There is a need for high-throughput, user-friendly genetic mutation detection methods in clinical settings.

Purpose of the Study:

• To develop a high-throughput method for detecting multiple genetic mutations.
• To adapt Amplification Refractory Mutation System (ARMS) technology for use with low-density microarrays.
• To improve the ease-of-use and throughput of genetic mutation analysis for clinical applications.

Main Methods:

• Multiplex-ARMS-PCR was used to detect mutations in the cystic fibrosis transmembrane regulator (CFTR) gene.
• PCR fragments were labeled with Cy5 and hybridized to amine-modified probes on a low-density microarray.
• Mutation detection was confirmed using a commercial scanner and a custom-built fluorescent detector with software.

Main Results:

• The combined ARMS and low-density microarray system successfully identified multiple known CFTR gene mutations (DeltaF508, 1717-1G>A, G542X, 621+1G>T, N1303K).
• The system demonstrated high-throughput capabilities for genetic mutation analysis.
• The method proved to be simple and rapid for identifying specific genetic sequences.

Conclusions:

• The integration of ARMS and low-density microarray technologies offers a novel, high-throughput solution for genetic mutation detection.
• This approach significantly enhances the speed and efficiency of identifying multiple known mutations in genetic diseases like cystic fibrosis.
• The developed system is suitable for clinical applications requiring rapid and reliable genetic analysis.